...
首页> 外文期刊>Nano Today >Stimuli-responsive nanotheranostics based on lanthanide-doped upconversion nanoparticles for cancer imaging and therapy: current advances and future challenges
【24h】

Stimuli-responsive nanotheranostics based on lanthanide-doped upconversion nanoparticles for cancer imaging and therapy: current advances and future challenges

机译:基于镧系元素的癌症成像和治疗的刺激型纳米移植物:目前的进步和未来挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Theranostic nanoplatform integrated with concurrent diagnostic and therapeutic capabilities has attracted increasing attentions recently in the field of nanomedicine since it offers great opportunities in the fight against various major diseases, such as cancer. In recent years, lanthanide-doped upconvertion nanoparticles (UCNPs), have been explored for potential applications in cancer diagnostics and treatment owing to their unique merits such as enhancing penetration depths and minimizing background autofluorescence, photo-bleaching as well as photodamage to biological specimens, and reducing adverse side effects of NIR triggered treatments. Of particular interest is to construct stimuli-responsive nanotheranostic platforms based on UCNPs that imaging and anticancer activities in response to various internal/external stimuli. In this review article, we would like to focus on the recent progress of UCNPs in their applications of stimuli-responsive theranostics that trigger the diagnostic and therapeutic functions in response to various stimuli, including near infrared (NIR) light, pH, glutathione (GSH), reactive oxygen species (ROS), enzyme, and temperature. Furthermore, the future directions and challenges in the development of UCNPs for stimuli-responsive theranostics are discussed. (C) 2019 Elsevier Ltd. All rights reserved.
机译:随着同时诊断和治疗能力集成的治疗纳米纳薄表格最近在纳米医生领域吸引了越来越多的注意事项,因为它在对抗各种主要疾病(如癌症)的斗争中提供了很大的机会。近年来,已探讨含镧 - 掺杂的上变纳米颗粒(UCNP),用于癌症诊断和治疗中的潜在应用,因为它们的独特优点,例如增强渗透深度和最小化背景自发荧光,光漂白以及光墨来生物标本,减少NIR触发治疗的不良副作用。特别感兴趣的是基于UCNP构建刺激响应性纳米移植平台,以应对各种内部/外部刺激的成像和抗癌活动。在本综述文章中,我们希望专注于UCNP在刺激响应性治疗的应用中的最新进展,以应对各种刺激,包括近红外(NIR)光,pH,谷胱甘肽(GSH ),反应性氧物种(ROS),酶和温度。此外,讨论了未来的UCNPS用于刺激响应治疗的UCNP的未来方向和挑战。 (c)2019年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号